Peek Technology LLC (Peek), located in the Biocube Centre San Jose, specialises in the design, fabrication and manufacture of test cartridges for the detection of one or more biomarkers in the same sample (i.e., multi/omni-plex platforms). Its team collectively has over 60 years of experience developing reagents, test chemistries and the design and engineering of test cartridges. Its founder was actively involved in the development of the first in-clinic HbA1c test, the A1cNow®, marketed by Bayer Diabetes Care until December 2013. It was the first FDA 510K approved (2002) point-of-care product on the market for the rapid diagnosis and management of diabetes in the human health care market.
AniPOC have formalised a development agreement with Peek.